A phase I/II clinical trial of carbon ion radiotherapy with concurrent S-1 for operable pancreatic cancer(HIMAT1325)
Phase 1
Recruiting
- Conditions
- operable pancreatic cancer
- Registration Number
- JPRN-UMIN000016436
- Lead Sponsor
- Ion Beam Therapy Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1)Metallic stent at the bile duct 2)Invasion to mucosal membrane of stomach or intestine 3)Use of flu cytosine, phenytoin, or warfarin potassium 4)Past history of irradiation to the target region 5)Active double cancers 6)Uncontrolled severe infection 7)Uncontrolled severe complication 8)Other medical or psychological unsuitable reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Phase 1: normal tissue effect during observation period Phase 2: local control rate
- Secondary Outcome Measures
Name Time Method